IDH1 and central nervous system cancer: By contrast Pal’a et al43 examined only IDH mutant grade 2 glioma patients and found a negative impact of adjuvant chemoradiotherapy on EFS and OS after adjusting for age over 40 years, extent of resection, recurrent surgery and histology.